Publikationen 2001
A single-nucleotide polymorphism in the sterol-regulatory element- binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
Miserez A R, Muller P Y, Barella L, Schwietert M, Erb P, Vernazza P L, Battegay M
AIDS 2001;15:2045-2049
Importance of mental health assessment in HIV-infected outpatients
Zinkernagel C, Taffe P, Rickenbach M, Amiet R, Ledergerber B, Volkart A C, Rauchfleisch U, Kiss A, Werder V, Vernazza P L, Battegay M
JAIDS 2001;28 / 3:240-249
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance
Yerly S, Vora S, Rizzardi P, Chave JP,Vernazza PL, Flepp M, Telenti A, Battegay M, Veuthey AL, Bru JP, Rickenbach M, Hirschel B, Perrin L and the Swiss HIV Cohort Study
AIDS 2001;15:2287-2292
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Fellay J, Boubaker K, Ledergerber B, Bernasconi E, Furrer H, Battegay M, Hirschel B, Vernazza P L, Francioli P, Greub G, Flepp M, Telenti A
Lancet 2001;358:1322-1327
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy
Rossi M, Flepp M, Telenti A, Schiffer V, Egloff N, Bucher H, Vernazza PL, Bernasconi E, Weber R, Rickenbach M, Furrer H
SMW 2001;131:471-477
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients
Battegay M, Vernazza PL, Bernasconi E, Flepp M, Sendi P, Erb P, Malinverni R, Jaccard C, Morgenthaler S, Bedoucha V, Hirschel B
HIV Med 2001;2:35-42
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection
Bisset LR, Cone RW, Fischer M, Battegay M, Vernazza PL, Dubs RW, Weber R, Grob PJ, Opravil M
JAIDS 2001;27 / 3:266-271
HIV transmission after suspension of highly active antiretroviral therapy
Bernasconi E, Vernazza PL, Bernasconi A, Hirschel B
JAIDS 2001;27 / 2:209
A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers
King AM, Osterwalder JJ, Vernazza PL
SMW 2001;131:10-14
Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS
Quinlivan EB, Wang RX, Stewart PW, Kolmoltri C, Regamey N, Erb P, Vernazza PL
J Med Virol 2001;64:157-166
Biological correlates of sexual transmission of HIV: practical consequences and potential targets for public health
Vernazza PL, Kashuba DM, Cohen MS
Rev Med Microbiol 2001;12 / 3:131-142
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model
Chakraborty H, Sen PK, Helms RW, Vernazza PL, Fiscus SA, Eron JJ, Patterson BK, Coombs RW, Krieger JN, Cohen MS
AIDS 2001;15 / 5:621-627
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Phillips A N, Staszewski S, Weber R, Kirk O, Francioli P, Miller V, Vernazza PL, Lundgren J D, Ledergerber B
JAMA 2001;286:2560-2567
Genital shedding of HIV-1 despite successful antiretroviral therapy
Vernazza PL
Lancet. 2001 Nov 10;358(9293):1564
